liljasol
@liljasolnes
Followers
346
Following
444
Media
6
Statuses
304
Joined November 2016
📢 Deadline Extended! Nominate outstanding women for WIMIN Awards at #WMIC2025 by Aug 8. Celebrate leaders, innovators, and rising stars in molecular imaging! 🌟✨ Submit now: https://t.co/HfAQWXy3Jf
#WIMIN #WomenInSTEM #MolecularImaging
0
2
3
Continuing education: Treatment response evaluation in prostate cancer using PSMA PET/CT. https://t.co/FmNoMRHzI6
#NuclearMedicine #RPTherapy #ProstateCancer @liljasolnes @FrancescoCeci13 @DrAGafita
0
14
36
Evidence-based clinical protocols to monitor efficacy of ¹⁷⁷Lu-PSMA #RPTherapy in metastatic castration-resistant #ProstateCancer using real-world data. https://t.co/Ou9jHDEYAH
#NuclearMedicine @DrAGafita @liljasolnes @UnterrainerLena @MUnterrainerMD
0
8
31
https://t.co/J87i06w513 Excellent evaluation of #PSMA #PET #molecularimaging for response assessment in #prostatecancer from @DrAGafita @liljasolnes @Hopkins_Rad @UNCRadiology
pubmed.ncbi.nlm.nih.gov
In recent years, there has been a headlong rush into the use of prostate-specific membrane antigen (PSMA)-targeted PET for the staging and restaging of men with prostate cancer (PC). To date, there...
0
4
8
Diagnostic radiopharmaceuticals: A sustainable path to the improvement of patient care. https://t.co/pL3zBtljjm
#MolecularImaging #Theranostics #NuclearMedicine @liljasolnes @DrAGafita
0
6
15
Renal function has no detectable affect on renal mass sestamibi uptake https://t.co/u1AVkLPwpL
@michael_gorin @liljasolnes @AlirezaAmin10 @nirmishsingla
pubmed.ncbi.nlm.nih.gov
However, further research with larger sample sizes is required to validate and generalize these findings. Ultimately, understanding the broad variety of applicability of 99m Tc-sestamibi uptake for...
0
2
7
Diagnostic radiopharmaceuticals: A sustainable path to the improvement of patient care. https://t.co/MgWifwvWzU
#NuclearMedicine #MedicalImaging @liljasolnes @DrAGafita
0
5
6
Mark your calendars for #WMIC2025! 📅 September 29 - October 3, 2025 📍 Anchorage, Alaska, USA Join the global community for cutting-edge discussions in a unique natural setting that inspires creativity. Stay tuned for updates on abstracts, registration, and exciting events!
0
3
6
Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction out on Journal of Nuclear Medicine☢️ https://t.co/ghwsJG5yUF The study investigated the real-world efficacy and
2
14
27
Congratulations to Dr. Peter Caravan on receiving our highest honor, the prestigious Gold Medal Award at #WMIC2024! 🏅 Join us in celebrating this exceptional achievement! #MolecularImaging #ResearchExcellence #WMIS
1
3
27
Extremely proud of our latest work on renal masses: a nuanced look at #sestamibi #molecularimaging in chromophobe #RCC. Particular great work from Dr. Salikh Murtazaliev @uarizona. @liljasolnes @UNCRadiology @allaf_mo @michael_gorin @gottsled
pubmed.ncbi.nlm.nih.gov
Based on current histopathologic classification methods, it is likely that the "false-positive" rate of uptake on renal sestamibi scans with chRCC has been over-stated. Further study is warranted to...
0
3
9
Check out our latest review on #renalmass molecular imaging. More from us soon on this exciting topic! #sestamibi #girentuximab @liljasolnes @michael_gorin @UNCRadiology @gottsled
pubmed.ncbi.nlm.nih.gov
Anatomic imaging with contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) has long been the mainstay of renal mass characterization. However, those modalities are often...
0
2
5
GI transit scintigraphic exams play a central role in diagnosis & treatment of GI disorders & are developed for use in evaluating small & large bowel transit. Let’s learn more from Banks and team! 1/7 https://t.co/2tFEuGkW6J
#RGphx #NucMed
@Radiographics @elojeimy
1
6
19
New @AJR_Radiology Accepted Manuscript: "Beyond the AJR: Improving Screening Rates With Bulk Mammogram Orders and Text Messages" By Drs Woodard & Yalniz @UABRadiology
https://t.co/7lBNJ3UikP
0
3
4
🎉 A big thank you to our incredible WMIC community for your amazing late-breaking abstracts! Your cutting-edge research drives our field forward. Didn't submit? No worries! There's still plenty to enjoy at #WMIC2024. We'll see you in Montreal for an unforgettable conference!
0
2
8
🌟 Celebrating International Women in Engineering Day! 🚀 From groundbreaking innovations to shaping the future of healthcare and technology, women engineers lead the way! 💪 #INWED #WomenInEngineering #MolecularImaging #WMIS #WIMIN
0
2
6
Due to popular demand, the abstract submission deadline for #WMIC2024 has been extended! The NEW late-breaking abstract submission deadline is: Friday, June 21st, 2024 at 11:59 PM PDT Start preparing your abstracts now! More details at https://t.co/82lPm4DzCw
0
6
6
Congratulations to our fantastic team at Johns Hopkins Theranostics Center for being recognized by @SNM_MI a Therapy Center of Excellence! @liljasolnes @AveryS32342 @daniellerill Jeffrey Young @Hopkins_Rad
The JHH theranostics team was recently recognized by @SNM_MI as a Radiopharmaceutical Therapy Center of Excellence! The designation aims to ensure patient access to high-quality radiopharmaceutical therapy. Congratulations to our theranostics team for a well-deserved honor!
0
2
5
Kudos to Dr. Laurence Carroll, who recently presented at the 266th American Chemical Society Meeting in New Orleans, speaking on “Investigating the Mechanism of Aluminum Fluoride Chelation”. The work has also been accepted for journal publication.
0
1
6
Not quite definitive yet but we may have a clinical neuroradiology fellowship spot (ACGME) opening at Johns Hopkins starting July 2024 (or as close to that as possible). If you are interested please send me a message; please share with colleagues as well. @hopkinsneurorad
5
21
66